Listed forestry biotechnology company Rubicon says it will appeal a US$53 million ruling in favour of nine former employees of its part-owned seedling company ArborGen.
Listed forestry biotechnology company Rubicon says it will appeal a US$53 million ruling in favour of nine former employees of its part-owned seedling company ArborGen.